• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酚羟基取代对基于2-二茂铁基-1-苯基-1-丁烯基序的化合物的电子转移和抗癌性能的影响。

The influence of phenolic hydroxy substitution on the electron transfer and anti-cancer properties of compounds based on the 2-ferrocenyl-1-phenyl-but-1-ene motif.

作者信息

Hillard Elizabeth Anne, Pigeon Pascal, Vessières Anne, Amatore Christian, Jaouen Gérard

机构信息

Laboratoire de Chimie et Biochimie des Complexes Moléculaires, UMR CNRS 7576, Ecole Nationale Supérieure de Chimie de Paris, 11 rue Pierre et Marie Curie, 75231, Paris, Cedex 05, France.

出版信息

Dalton Trans. 2007 Nov 21(43):5073-81. doi: 10.1039/b705030e. Epub 2007 Sep 28.

DOI:10.1039/b705030e
PMID:17992292
Abstract

The ferrocenyl compound 2-ferrocenyl-1,1-bis(4-hydroxyphenyl)-but-1-ene (), is very cytotoxic against breast cancer cells (IC(50) = 0.44 microM against MDA-MB-231). We now report the synthesis of a new series of para- and meta- substituted mono- and di- ferrocenyl phenols [2-ferrocenyl-1-(3-hydroxyphenyl)-1-phenyl-but-1-ene (), 2-ferrocenyl-1-(3-hydroxyphenyl)-1-(4-hydroxyphenyl)-but-1-ene (), 1,2-di-ferrocenyl-1-(4-hydroxyphenyl)-but-1-ene (), and 1,2-di-ferrocenyl-1-(3-hydroxyphenyl)-but-1-ene ()] and their electrochemical and biochemical properties, especially in comparison to the previously reported "standard" compounds [2-ferrocenyl-1-(4-hydroxyphenyl)-1-phenyl-but-1-ene () and ()]. We also report the synthesis and characterization of the diphenyl analogue, 2-ferrocenyl-1,1-diphenyl-but-1-ene (). This structure-activity relationship study was motivated by our hypothesis that the cytotoxicity of is related to its ability to form a quinone methide structure after two in situ 1-electron oxidations, a process which requires the presence of at least one p-phenol. The mono-ferrocenyl compounds (including those previously reported) are reasonably well recognized by the oestrogen receptors alpha (RBAs = 0.9-9.6%) and beta (RBAs = 0.28-16.3%), although the bulkier di-ferrocenyl compounds show very little affinity. In vitro, the cytotoxic effects of the phenolic complexes are related to the positioning of the hydroxyl group (para- superior to meta-), and to the number of ferrocenyl groups (one superior to two), with IC(50) values against the MDA-MB-231 cell line ranging from 0.44-3.5 microM. On the hormone-dependent breast cancer cell line MCF-7, the observed effect seems to be the result of two components, one cytotoxic (antiproliferative) and one estrogenic (proliferative). Electrochemical studies show that only the compounds with a p-phenol engage in proton-coupled intramolecular electron transfer.

摘要

二茂铁基化合物2-二茂铁基-1,1-双(4-羟基苯基)-丁-1-烯()对乳腺癌细胞具有很强的细胞毒性(对MDA-MB-231细胞的IC(50) = 0.44微摩尔)。我们现在报告一系列新的对位和间位取代的单二茂铁基和二二茂铁基苯酚的合成[2-二茂铁基-1-(3-羟基苯基)-1-苯基-丁-1-烯()、2-二茂铁基-1-(3-羟基苯基)-1-(4-羟基苯基)-丁-1-烯()、1,2-二二茂铁基-1-(4-羟基苯基)-丁-1-烯()和1,2-二二茂铁基-1-(3-羟基苯基)-丁-1-烯()]及其电化学和生化性质,特别是与先前报道的“标准”化合物[2-二茂铁基-1-(4-羟基苯基)-1-苯基-丁-1-烯()和()]进行比较。我们还报告了二苯基类似物2-二茂铁基-1,1-二苯基-丁-1-烯()的合成与表征。这项构效关系研究是基于我们的假设,即的细胞毒性与其在两次原位单电子氧化后形成醌甲基化物结构的能力有关,这一过程需要至少一个对苯酚的存在。单二茂铁基化合物(包括先前报道的那些)能被雌激素受体α(相对结合亲和力 = 0.9 - 9.6%)和β(相对结合亲和力 = 0.28 - 16.3%)较好地识别,尽管体积更大的二二茂铁基化合物显示出很小的亲和力。在体外,酚类配合物的细胞毒性作用与羟基的位置(对位优于间位)以及二茂铁基的数量(一个优于两个)有关,对MDA-MB-231细胞系的IC(50)值范围为0.44 - 3.5微摩尔。在激素依赖性乳腺癌细胞系MCF-7上,观察到的效应似乎是两种成分的结果,一种是细胞毒性(抗增殖),一种是雌激素样(增殖)。电化学研究表明,只有具有对苯酚的化合物参与质子耦合的分子内电子转移。

相似文献

1
The influence of phenolic hydroxy substitution on the electron transfer and anti-cancer properties of compounds based on the 2-ferrocenyl-1-phenyl-but-1-ene motif.酚羟基取代对基于2-二茂铁基-1-苯基-1-丁烯基序的化合物的电子转移和抗癌性能的影响。
Dalton Trans. 2007 Nov 21(43):5073-81. doi: 10.1039/b705030e. Epub 2007 Sep 28.
2
Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro.通过引入二茂铁对双酚雌激素特性的修饰。体外产生抗增殖作用。
J Med Chem. 2005 Jun 16;48(12):3937-40. doi: 10.1021/jm050251o.
3
Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.有机金属特异性雌激素受体调节剂(SERM)、二茂铁雌酚和羟基二茂铁雌酚的合成、生化特性及分子模拟研究:羟基二茂铁雌酚对激素依赖性和激素非依赖性乳腺癌细胞系具有抗增殖作用的证据
Chemistry. 2003 Nov 7;9(21):5223-36. doi: 10.1002/chem.200305024.
4
A series of unconjugated ferrocenyl phenols: prospects as anticancer agents.一系列非共轭二茂铁基苯酚:作为抗癌剂的前景
ChemMedChem. 2006 May;1(5):551-9. doi: 10.1002/cmdc.200500035.
5
Role of aromatic substituents on the antiproliferative effects of diphenyl ferrocenyl butene compounds.芳族取代基对二苯基二茂铁基丁烯化合物抗增殖作用的影响
Dalton Trans. 2009 Jun 14(22):4318-26. doi: 10.1039/b819812h. Epub 2009 Feb 24.
6
Synthesis and structure-activity relationships of ferrocenyl tamoxifen derivatives with modified side chains.具有修饰侧链的二茂铁基他莫昔芬衍生物的合成及其构效关系
Chemistry. 2009;15(3):684-96. doi: 10.1002/chem.200801108.
7
The presence of a ferrocenyl unit on an estrogenic molecule is not always sufficient to generate in vitro cytotoxicity.雌激素分子上存在二茂铁基单元并不总是足以在体外产生细胞毒性。
ChemMedChem. 2006 Nov;1(11):1275-81. doi: 10.1002/cmdc.200600176.
8
Organometallic cyclic polyphenols derived from 1,2-(alpha-keto tri or tetra methylene) ferrocene show strong antiproliferative activity on hormone-independent breast cancer cells.有机金属环状多酚衍生自 1,2-(α-酮三或四亚甲基)二茂铁,对激素非依赖性乳腺癌细胞具有很强的抗增殖活性。
Dalton Trans. 2010 Aug 28;39(32):7444-50. doi: 10.1039/c0dt00169d. Epub 2010 Jul 8.
9
Synthesis, structure, and in vitro antitumor activity of some glycoside derivatives of ferrocenyl-chalcones and ferrocenyl-pyrazolines.二茂铁基查尔酮和二茂铁基吡唑啉的一些糖苷衍生物的合成、结构及体外抗肿瘤活性
ChemMedChem. 2006 Oct;1(10):1119-25. doi: 10.1002/cmdc.200600052.
10
Synthesis, oxidation chemistry and cytotoxicity studies on ferrocene derivatives of diethylstilbestrol.二苯乙烯衍生物二乙基己烯雌酚的铁衍生物的合成、氧化化学和细胞毒性研究。
Dalton Trans. 2009 Dec 28(48):10871-81. doi: 10.1039/b913570g. Epub 2009 Oct 27.

引用本文的文献

1
Steroids Bearing Heteroatom as Potential Drugs for Medicine.含杂原子甾体作为潜在的医药用药物
Biomedicines. 2023 Oct 3;11(10):2698. doi: 10.3390/biomedicines11102698.
2
Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies.基于过渡金属-芳烃体系的有机金属化合物作为抗癌剂的研究范围:从经典范式到靶向多种策略。
RSC Adv. 2019 Jan 24;9(6):3239-3278. doi: 10.1039/c8ra07926a. eCollection 2019 Jan 22.
3
Chemical alternative for cell identification and cross-contamination detection.
用于细胞识别和交叉污染检测的化学替代方法。
3 Biotech. 2022 Mar;12(3):78. doi: 10.1007/s13205-022-03144-z. Epub 2022 Feb 25.
4
Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by FAS Expression Dynamics and Transcriptomic Subtypes.铁基金属药物在胶质母细胞瘤中的反应异质性与化学结构差异相关,受 FAS 表达动力学和转录亚型驱动。
Int J Mol Sci. 2021 Sep 27;22(19):10404. doi: 10.3390/ijms221910404.
5
Synthetic ()-3-Phenyl-5-(phenylamino)-2-styryl-1,3,4-thiadiazol-3-ium Chloride Derivatives as Promising Chemotherapy Agents on Cell Lines Infected with HTLV-1.合成 ()-3-苯基-5-(苯氨基)-2-苯乙烯基-1,3,4-噻二唑-3-翁氯化物衍生物作为 HTLV-1 感染细胞系的有前途的化疗药物。
Molecules. 2020 May 29;25(11):2537. doi: 10.3390/molecules25112537.
6
Antiplasmodial activity of iron(II) and ruthenium(II) organometallic complexes against Plasmodium falciparum blood parasites.铁(II)和钌(II)有机金属配合物对恶性疟原虫血液寄生虫的抗疟活性。
Mem Inst Oswaldo Cruz. 2015 Dec;110(8):981-8. doi: 10.1590/0074-02760150163. Epub 2015 Nov 24.
7
Atypical McMurry cross-coupling reactions leading to a new series of potent antiproliferative compounds bearing the key [ferrocenyl-ene-phenol] motif.导致一系列带有关键[二茂铁基-烯-苯酚]基序的新型强效抗增殖化合物的非典型麦克默里交叉偶联反应。
Molecules. 2014 Jul 17;19(7):10350-69. doi: 10.3390/molecules190710350.
8
Metallocenes as Target Specific Drugs for Cancer Treatment.金属茂作为癌症治疗的靶向特异性药物。
Inorganica Chim Acta. 2012 Dec 1;393:36-52. doi: 10.1016/j.ica.2012.06.007. Epub 2012 Jun 21.
9
Synthesis of hydroxyferrocifen and its abilities to protect DNA and to scavenge radicals.羟基二茂铁的合成及其保护 DNA 和清除自由基的能力。
J Biol Inorg Chem. 2011 Dec;16(8):1169-76. doi: 10.1007/s00775-011-0805-8. Epub 2011 Jun 24.
10
Organometallic anticancer compounds.有机金属抗癌化合物。
J Med Chem. 2011 Jan 13;54(1):3-25. doi: 10.1021/jm100020w. Epub 2010 Nov 15.